XML 27 R13.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Reporting | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Segment Reporting | (7) Segment Reporting Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including, but not limited to, information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising and design and construction. The chief operating decision making group for our acute care services and behavioral health care services is comprised of our President and Chief Executive Officer and the Presidents of each operating segment. The Presidents for each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2021. The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment to the extent possible, and overhead expenses incurred on behalf of both segments are captured and allocated to each segment based upon each segment’s respective percentage of total operating expenses.
|  | Three months ended September 30, 2022 |
|  | Acute Care Hospital Services |  |  | Behavioral Health Services (a) |  |  | Other |  |  | Total Consolidated |
|  | (Amounts in thousands) |
Gross inpatient revenues |  | $ | 9,875,794 |  |  | $ | 2,582,448 |  |  | $ | - |  |  | $ | 12,458,242 |
Gross outpatient revenues |  | $ | 6,379,324 |  |  | $ | 248,167 |  |  | $ | - |  |  | $ | 6,627,491 |
Total net revenues |  | $ | 1,919,678 |  |  | $ | 1,434,828 |  |  | $ | (18,479 | ) |  | $ | 3,336,027 |
Income/(loss) before allocation of corporate overhead and income taxes |  | $ | 129,241 |  |  | $ | 237,949 |  |  | $ | (132,978 | ) |  | $ | 234,212 |
Allocation of corporate overhead |  | $ | (63,242 | ) |  | $ | (44,882 | ) |  | $ | 108,124 |  |  | $ | 0 |
Income/(loss) after allocation of corporate overhead and before income taxes |  | $ | 65,999 |  |  | $ | 193,067 |  |  | $ | (24,854 | ) |  | $ | 234,212 |
Total assets as of September 30, 2022 |  | $ | 6,039,787 |  |  | $ | 7,336,437 |  |  | $ | 2,676 |  |  | $ | 13,378,900 |
|  | Nine months ended September 30, 2022 |
|  | Acute Care Hospital Services |  |  | Behavioral Health Services (a) |  |  | Other |  |  | Total Consolidated |
|  | (Amounts in thousands) |
Gross inpatient revenues |  | $ | 29,821,756 |  |  | $ | 7,580,475 |  |  |  |  |  |  | $ | 37,402,231 |
Gross outpatient revenues |  | $ | 18,360,902 |  |  | $ | 773,769 |  |  |  |  |  |  | $ | 19,134,671 |
Total net revenues |  | $ | 5,707,510 |  |  | $ | 4,235,215 |  |  | $ | 9,665 |  |  | $ | 9,952,390 |
Income/(loss) before allocation of corporate overhead and income taxes |  | $ | 372,981 |  |  | $ | 693,694 |  |  | $ | (422,750 | ) |  | $ | 643,925 |
Allocation of corporate overhead |  | $ | (188,739 | ) |  | $ | (134,946 | ) |  | $ | 323,685 |  |  | $ | 0 |
Income/(loss) after allocation of corporate overhead and before income taxes |  | $ | 184,242 |  |  | $ | 558,748 |  |  | $ | (99,065 | ) |  | $ | 643,925 |
Total assets as of September 30, 2022 |  | $ | 6,039,787 |  |  | $ | 7,336,437 |  |  | $ | 2,676 |  |  | $ | 13,378,900 |
|  | Three months ended September 30, 2021 |
|  | Acute Care Hospital Services |  |  | Behavioral Health Services (a) |  |  | Other |  |  | Total Consolidated |
|  | (Amounts in thousands) |
Gross inpatient revenues |  | $ | 9,497,975 |  |  | $ | 2,470,401 |  |  | $ | 0 |  |  | $ | 11,968,376 |
Gross outpatient revenues |  | $ | 5,343,246 |  |  | $ | 242,976 |  |  | $ | 0 |  |  | $ | 5,586,222 |
Total net revenues |  | $ | 1,822,027 |  |  | $ | 1,328,293 |  |  | $ | 5,679 |  |  | $ | 3,155,999 |
Income/(loss) before allocation of corporate overhead and income taxes |  | $ | 208,638 |  |  | $ | 197,779 |  |  | $ | (119,527 | ) |  | $ | 286,890 |
Allocation of corporate overhead |  | $ | (58,452 | ) |  | $ | (43,120 | ) |  | $ | 101,572 |  |  | $ | 0 |
Income/(loss) after allocation of corporate overhead and before income taxes |  | $ | 150,186 |  |  | $ | 154,659 |  |  | $ | (17,955 | ) |  | $ | 286,890 |
Total assets as of September 30, 2021 |  | $ | 5,295,533 |  |  | $ | 7,106,832 |  |  | $ | 444,488 |  |  | $ | 12,846,853 |
|  | Nine months ended September 30, 2021 |
|  | Acute Care Hospital Services |  |  | Behavioral Health Services (a) |  |  | Other |  |  | Total Consolidated |
|  | (Amounts in thousands) |
Gross inpatient revenues |  | $ | 27,279,494 |  |  | $ | 7,471,742 |  |  | $ | 0 |  |  | $ | 34,751,236 |
Gross outpatient revenues |  | $ | 15,281,854 |  |  | $ | 756,068 |  |  | $ | 0 |  |  | $ | 16,037,922 |
Total net revenues |  | $ | 5,271,000 |  |  | $ | 4,075,127 |  |  | $ | 20,739 |  |  | $ | 9,366,866 |
Income/(loss) before allocation of corporate overhead and income taxes |  | $ | 600,419 |  |  | $ | 753,681 |  |  | $ | (367,535 | ) |  | $ | 986,565 |
Allocation of corporate overhead |  | $ | (174,786 | ) |  | $ | (129,169 | ) |  | $ | 303,955 |  |  | $ | 0 |
Income/(loss) after allocation of corporate overhead and before income taxes |  | $ | 425,633 |  |  | $ | 624,512 |  |  | $ | (63,580 | ) |  | $ | 986,565 |
Total assets as of September 30, 2021 |  | $ | 5,295,533 |  |  | $ | 7,106,832 |  |  | $ | 444,488 |  |  | $ | 12,846,853 |
| (a) | Includes net revenues generated from our behavioral health care facilities located in the U.K. amounting to approximately $167 million and $174 million for the three-month periods ended September 30, 2022 and 2021, respectively, and approximately $516 million and $511 million for the nine-month periods ended September 30, 2022 and 2021, respectively. Total assets at our U.K. behavioral health care facilities were approximately $1.119 billion and $1.338 billion as of September 30, 2022 and 2021, respectively.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration